Abstract

Goal: Current instruments for bulbar assessment exhibit technical limitations that hinder the execution of clinical studies. The volume conduction properties (VCP) of the tongue reflect ionic content and myofiber integrity and they can serve as a new biomarker for evaluating neurological disorders with bulbar dysfunction. Methods: We designed a standalone bioimpedance measurement system that enables accurate, multi-frequency measurement of tongue anisotropic VCP including conductivity and relative permittivity. The system includes a tongue depressor with 16 non-invasive surface sensors for electrical contact with the tongue at directions 0n}{}^{circ }, 45n}{}^{circ }, 90n}{}^{circ } and 150n}{}^{circ }. The depressor is interfaced with the tongue electronic system with Bluetooth connectivity, and a smartphone application. De-identified patient data is sent by email. Results: We first determined the accuracy of the hardware performing phantom measurements mimicking a broad range of tongue values and determined the error to be n}{}< 1%. We then validated our new technology measuring a cohort of 7 healthy human subjects under Institutional Review Board approval. Conclusions: None of the subjects who participated suffered discomfort or gag reflexes. The novel technique presented for intra-oral assessment of tongue VCP provides standard, objective and quantitative data potentially sensitive to alterations in tongue internal structure and composition.

Highlights

  • S PEECH and swallowing abnormalities accompany many neurological disorders

  • All four channels had resistors values ranging from 0.1 to 2 kΩ covering a broad range of tongue resistivity values

  • In vivo tongue impedance values measured with the User tongue array (UTA) depressor range from 100 to 300 Ω, where the precision of User tongue electronic system (UTES) is

Read more

Summary

Introduction

S PEECH and swallowing abnormalities accompany many neurological disorders. In amyotrophic lateral sclerosis (ALS) for example, approximately 25% of patients have predominantly such complaints, termed bulbar symptoms, at the. Gutierrez Pulido and S.B. Rutkove are with the Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call